NAMPT and polycystic ovary syndrome: Although two studies failed to highlight a significant difference between PCOS and healthy women [193,194] (Figure 11), most of the authors, and particularly the recent Sun et al. meta-analysis [195], found significantly higher plasma visfatin levels in PCOS patients [123,192,196,197,198,199,200,201,202] (Figure 11).